Evidence map›Paper›PMID 41940597›Full record

ArticleStatistics in medicine2026

A New Parametric Accelerated Failure Time Model for Semi-Competing Risks Data.

Antoniya Dineva, Oliver Kuss, Annika Hoyer

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Antoniya DinevaBiostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany.ORCID https://orcid.org/0009-0005-6329-6069
Oliver KussGerman Diabetes Center, Institute for Biometrics and Epidemiology, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Annika HoyerBiostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany.ORCID https://orcid.org/0000-0002-0241-9951

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In cohort studies, the occurrence of a specific disease is often of main interest. For proper modeling, death as a competing risk should be accounted for. Especially, the "semi-competing" character of the data has to be acknowledged: Disease occurrence (the non-terminal event) can be observed before death (the terminal event), but not vice versa. Hence, the terminal event might censor the non-terminal event but remains observable if the non-terminal event occurs first. The underlying setting can be described by an illness-death model incorporating transitions between the three states "healthy," "diseased," and "dead." This article aims to introduce a new method employing accelerated failure time (AFT) models for each of the three transitions between the states of the illness-death model. The major advantage of this approach is its intuitive and straightforward interpretation based on the survival instead of the hazard function, facilitating communication of results. We propose a parametric model by assuming Weibull distributions for the ages in the different states, modeling (1) the age at disease onset, (2) the age at death for patients without diagnosis, and (3) the age at death after diagnosis. We add random effects to adjust for intra-individual correlations, yielding a trivariate model. Model parameters are estimated by the maximum likelihood principle. The likelihood function incorporates left truncation for both terminal and non-terminal events, reflecting the delayed entry into the study cohort. As in cohort studies the diagnosis is usually made at intermittent follow-up visits and the exact age at disease onset is only known to lie in the interval between the last two visits, we finally consider interval censoring for the disease occurrence. The model is illustrated using data from the PAQUID study, focusing on dementia as a non-terminal event. Our approach leads to plausible results, confirming the findings by other existing methods. The overall performance is assessed by a simulation study, yielding promising results concerning the accuracy and numerical robustness of our model.

Indexed as

Models, StatisticalAge of OnsetCohort StudiesComputer SimulationHumansRisk AssessmentSurvival Analysiscohort studiescompeting riskstime‐to‐event modeltruncated data

Identifiers

PMID41940597
PMCPMC13051532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.